STADA Arzneimittel AG
↗Bad Vilbel, Germany
STADA Arzneimittel AG is a leading European pharmaceutical company headquartered in Bad Vilbel, Germany. The company follows a three-pillar strategy focused on Consumer Healthcare (OTC), Generics, and Specialty Pharmaceuticals, including a rapidly expanding portfolio of biosimilars. STADA is one of the largest players in the European generics market and has a significant global presence, selling products in approximately 120 countries.
In recent years, STADA has transitioned from a traditional generics manufacturer into a diversified healthcare platform. This growth has been fueled by aggressive M&A activity, including the acquisition of major consumer brands from Sanofi and GSK, and a strong push into specialty areas such as neurology (Parkinson's disease) and nephrology. The company is currently owned by CapVest Partners LLP following a multi-billion euro acquisition in late 2024/early 2025.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics, Specialty Pharma, and Consumer Health
SIZE & FINANCIALS
Employees:10000+
Revenue:€4.0B - €4.5B
Founded:1895
Ownership:private
Status:operating
FUNDING
Stage:Acquired
Investors:CapVest Partners LLP, Bain Capital (Minority), Cinven (Minority)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biosimilars, mAbs, Complex Generics
Active Trials:32
Trial Phases:Phase 1: 5 | Phase 2: 8 | Phase 3: 12 | Phase 4: 7
FDA Approvals:15
EMA Approvals:45
CORPORATE STRUCTURE
Parent Company:Nidda German Topco GmbH
Acquired By:CapVest Partners LLP (2024-09-01)
Subsidiaries:STADA Pymepharco (Vietnam), Hemofarm (Serbia), STADA Romania, Thornton & Ross (UK)
Key Partnerships:Bio-Thera Solutions (Biosimilars), Alvotech (Biosimilars), Xbrane Biopharma (Ranibizumab)
COMPETITION
Position:Leader
Competitors:Sandoz, Teva Pharmaceuticals, Viatris, Fresenius Kabi, Haleon (Consumer Health)
LEADERSHIP
Key Executives:
Peter Goldschmidt - CEO
Boris Döbler - CFO
Miguel Pagan Fernandez - CTO
Board Members:Günter von Au (Chairman), Michael Siefke, Eric Cornut
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of STADA Arzneimittel AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with STADA Arzneimittel AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.